Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11472576 | 0.97 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL14369217 | 0.79 | — | — | |
| SCHEMBL15570345 | 0.79 | GABRR1 (0.36) | — | |
| SCHEMBL15570489 | 0.79 | — | — | |
| SCHEMBL324235 | 0.74 | ALDH1A1 (0.31) | ALDH1A1 | |
| Nitric Acid SCHEMBL4417968 | 0.74 | CA5A (0.35) | — | |
| Nitric Acid SCHEMBL9205565 | 0.74 | CA5A (0.35) | — | |
| SCHEMBL3293940 | 0.70 | — | — | |
| Ammonia Solution, Strong SCHEMBL9793362 | 0.69 | — | — | |
| Water SCHEMBL11126730 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2887927-B1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINO-C2-C6-ALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-03-28 | — | — | EP | claimed |
| US-20180036259-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | MIRANDAPHARMACEUTICALS AG (CH) | 2018-02-08 | — | — | US | claimed |
| US-20180008558-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-01-11 | — | — | US | claimed |
| US-20170100350-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2017-04-13 | — | — | US | claimed |
| WO-2016135262-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | CARDIOLYNX AG (CH) | 2016-09-01 | — | — | WO | claimed |
| WO-2016135263-A1 | NO DONORS FOR THE TREATMENT OF STRESS-INDUCED PULMONARY HAEMORRHAGE IN ANIMALS | SCHERHAG ARMIN (CH) | 2016-09-01 | — | — | WO | claimed |
| US-20150216992-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2015-08-06 | — | — | US | claimed |
| EP-2887927-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | Cardiolynx AG (CH) | 2015-07-01 | — | — | EP | claimed |
| WO-2014029841-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2014-02-27 | — | — | WO | claimed |
| EP-2887927-B1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINO-C2-C6-ALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-03-28 | — | — | EP | disclosed |
| US-20180036259-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | MIRANDAPHARMACEUTICALS AG (CH) | 2018-02-08 | — | — | US | disclosed |
| US-20180008558-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2018-01-11 | — | — | US | disclosed |
| US-20170100350-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2017-04-13 | — | — | US | disclosed |
| WO-2016135262-A1 | NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION | CARDIOLYNX AG (CH) | 2016-09-01 | — | — | WO | disclosed |
| WO-2016135263-A1 | NO DONORS FOR THE TREATMENT OF STRESS-INDUCED PULMONARY HAEMORRHAGE IN ANIMALS | SCHERHAG ARMIN (CH) | 2016-09-01 | — | — | WO | disclosed |
| US-20150216992-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2015-08-06 | — | — | US | disclosed |
| EP-2887927-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | Cardiolynx AG (CH) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014029841-A1 | EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE | CARDIOLYNX AG (CH) | 2014-02-27 | — | — | WO | disclosed |